Brief: Xilio Therapeutics Announced Pricing Of Its Initial Public Offering
Oct 21 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS - ANNOUNCED PRICING OF ITS INITIAL
PUBLIC
OFFERING OF 7,353,000 SHARES OF ITS COMMON STOCK AT PRICE TO
PUBLIC OF $16.00 PER SHARE
Source text for Eikon: ID:nBw9pKCGQa
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla